Headshot of Maureen Stewart
Profiles

Maureen Stewart, PhD

Research Associate Professor, Health Law, Policy & Management - Boston University School of Public Health

Biography

Dr. Stewart's research interests include the financing, payment, and organization of behavioral health services. Her research focuses on policy and system approaches improve access to and quality of alcohol and drug treatment services and to reduce racial, ethnic, and geographic disparities in substance use treatment services.

Dr. Stewart is currently PI of a NIDA study examining how Medicaid managed care plan policies influence access to and quality of opioid use disorder treatment, co-investigator of a NIDA study of the hub-and-spoke model of opioid treatment in Washington State, and quantitative lead of an evaluation of Massachusetts' efforts to improve access to medication for opioid use disorder. With funding from ASPE, Dr. Stewart recently completed case studies of emergency departments’ efforts to expand access to substance use treatment which started with offering medication treatment for opioid use disorder and expanded to engaging patients in treatment for alcohol and other substance use disorders.

Education

  • Brandeis University, PhD Field of Study: Social Policy
  • Brandeis University, MA Field of Study: Social Policy
  • Boston College, BA Field of Study: Economics

Publications

  • Published on 4/27/2026

    Feltus SR, Andrews CM, Peterson L, Grogan CM, Abraham AJ, Hinds OM, Stewart MT. Medicaid Managed Care Plan Alignment With State Substance Use Disorder Treatment Coverage Requirements. Milbank Q. 2026 Apr 27. PMID: 42037268.

    Read At: PubMed
  • Published on 3/20/2026

    Hodgkin D, Daily SM, Panas L, Ritter G, Stewart MT, Reif S. Treatment for Comorbid Mental Health Disorders Among Patients Treated for Opioid Disorder: The Role of a Hub and Spoke Intervention. Community Ment Health J. 2026 Mar 20. PMID: 41860676.

    Read At: PubMed
  • Published on 3/2/2026

    Tschampl CA, Feltus SR, Soranno E, Bratberg J, Stewart MT, Dawson M, Green TC. Treating Opioid Use Disorder With Methadone in Pharmacies. JAMA Netw Open. 2026 Mar 02; 9(3):e260703. PMID: 41838002.

    Read At: PubMed
  • Published on 3/1/2026

    Daily SM, Reif S, Speaker E, Panas L, Ritter GT, Stewart MT. Expanding access to low-barrier opioid use disorder treatment in non-traditional settings: Washington's opioid treatment network. J Rural Health. 2026 Mar; 42(2):e70139. PMID: 41891139.

    Read At: PubMed
  • Published on 9/5/2025

    Andrews CM, Feltus SR, Horgan CM, Thomas CP, Hodgkin D, Stewart MT. Coverage for Opioid Use Disorder Medications in Medicaid Managed Care. JAMA Health Forum. 2025 Sep 05; 6(9):e253239. PMID: 40911329.

    Read At: PubMed
  • Published on 9/1/2025

    Stewart MT, Feltus SR, Tschampl CA, Bratberg JP, Green TC. Key-Informant Perspectives On Pharmacy-Based Methadone Treatment For Opioid Use Disorder In The US. Health Aff (Millwood). 2025 Sep; 44(9):1164-1172. PMID: 40893075.

    Read At: PubMed
  • Published on 8/7/2025

    Reif S, Stewart MT, Daily SM, Panas L, Ritter GA, Brolin MF, Lee MT, Wicks JJ. Effectiveness of Washington State's hub and spoke model to improve opioid use disorder outcomes. Health Aff Sch. 2025 Aug; 3(8):qxaf157. PMID: 40896384.

    Read At: PubMed
  • Published on 6/25/2025

    Stewart MT, Daily SM, Panas L, Feltus SR, Lee M, Ritter G, Reif S. Differential Changes in Use of Medications for Opioid Use Disorder by Race-Ethnicity: Effects of a Hub-and-Spoke Model. Psychiatr Serv. 2025 Sep 01; 76(9):795-800. PMID: 40556450.

    Read At: PubMed
  • Published on 6/2/2025

    Stewart MT, Feltus SR, Andrews C, Hodgkin D, Thomas CP, Horgan CM. Predictors of Medicaid managed care plan performance on opioid use disorder treatment quality metrics. Drug Alcohol Depend. 2025 Sep 01; 274:112742. PMID: 40482519.

    Read At: PubMed
  • Published on 5/1/2025

    Feltus SR, Bratberg J, Balkovski S, Stewart MT. Medicaid Managed Care Naloxone Coverage and Management. JAMA Netw Open. 2025 May 01; 8(5):e2512866. PMID: 40440018.

    Read At: PubMed

News & In the Media